Stifel Financial
TEVA icon

Stifel Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Stifel Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.73M Sell
198,546
-9,049
-4% -$301K 0.01% 1242
2026
Q1 		$6.25M Buy
207,595
+101,843
+96% +$3.28M 0.01% 1221
2025
Q4 		$3.3M Buy
105,752
+14,493
+16% +$357K ﹤0.01% 1582
2025
Q3 		$1.84M Sell
91,259
-1,751
-2% -$30.8K ﹤0.01% 1975
2025
Q2 		$1.56M Sell
93,010
-2,058
-2% -$33.2K ﹤0.01% 2015
2025
Q1 		$1.46M Buy
95,068
+6,590
+7% +$118K ﹤0.01% 1981
2024
Q4 		$1.95M Buy
88,478
+22,087
+33% +$402K ﹤0.01% 1798
2024
Q3 		$1.2M Buy
66,391
+23,283
+54% +$407K ﹤0.01% 2110
2024
Q2 		$701K Buy
43,108
+4,863
+13% +$74.9K ﹤0.01% 2401
2024
Q1 		$540K Buy
38,245
+3,387
+10% +$42.7K ﹤0.01% 2567
2023
Q4 		$364K Sell
34,858
-3,807
-10% -$35.5K ﹤0.01% 2738
2023
Q3 		$394K Sell
38,665
-13,704
-26% -$128K ﹤0.01% 2631
2023
Q2 		$394K Buy
52,369
+5,585
+12% +$45.3K ﹤0.01% 2669
2023
Q1 		$414K Buy
46,784
+3,917
+9% +$38.7K ﹤0.01% 2624
2022
Q4 		$391K Buy
42,867
+12,322
+40% +$108K ﹤0.01% 2615
2022
Q3 		$247K Buy
30,545
+273
+0.9% +$2.41K ﹤0.01% 2837
2022
Q2 		$227K Buy
30,272
+149
+0.5% +$1.3K ﹤0.01% 2911
2022
Q1 		$283K Sell
30,123
-7,078
-19% -$59.1K ﹤0.01% 2906
2021
Q4 		$298K Buy
37,201
+4,190
+13% +$37.8K ﹤0.01% 2914
2021
Q3 		$321K Sell
33,011
-2,851
-8% -$26.7K ﹤0.01% 2863
2021
Q2 		$355K Sell
35,862
-2,024
-5% -$21.4K ﹤0.01% 2787
2021
Q1 		$437K Sell
37,886
-6,676
-15% -$76.6K ﹤0.01% 2568
2020
Q4 		$430K Sell
44,562
-5,491
-11% -$52.6K ﹤0.01% 2414
2020
Q3 		$452K Buy
50,053
+4,678
+10% +$49.5K ﹤0.01% 2146
2020
Q2 		$560K Sell
45,375
-8,689
-16% -$98.3K ﹤0.01% 1961
2020
Q1 		$488K Buy
54,064
+9,018
+20% +$92.4K ﹤0.01% 1888
2019
Q4 		$444K Sell
45,046
-47,822
-51% -$427K ﹤0.01% 2337
2019
Q3 		$635K Buy
92,868
+27,661
+42% +$212K ﹤0.01% 2032
2019
Q2 		$607K Sell
65,207
-303,215
-82% -$3.66M ﹤0.01% 2109
2019
Q1 		$5.77M Sell
368,422
-962
-0.3% -$17K 0.02% 751
2018
Q4 		$5.68M Sell
369,384
-10,755
-3% -$220K 0.02% 708
2018
Q3 		$8.18M Buy
380,139
+9,695
+3% +$225K 0.02% 630
2018
Q2 		$9M Buy
370,444
+3,922
+1% +$80K 0.03% 584
2018
Q1 		$6.26M Sell
366,522
-64,836
-15% -$1.27M 0.02% 696
2017
Q4 		$8.19M Sell
431,358
-136,654
-24% -$2.06M 0.03% 601
2017
Q3 		$10M Sell
568,012
-116,495
-17% -$2.62M 0.03% 505
2017
Q2 		$22.7M Sell
684,507
-122,884
-15% -$3.8M 0.08% 248
2017
Q1 		$25.9M Buy
807,391
+40,994
+5% +$1.4M 0.1% 215
2016
Q4 		$27.8M Buy
766,397
+125,505
+20% +$5.01M 0.12% 193
2016
Q3 		$29.5M Sell
640,892
-7,522
-1% -$392K 0.13% 178
2016
Q2 		$32.6M Buy
648,414
+11,711
+2% +$623K 0.15% 149
2016
Q1 		$34.1M Sell
636,703
-37,261
-6% -$2.19M 0.18% 125
2015
Q4 		$44.2M Buy
673,964
+43,175
+7% +$2.67M 0.23% 113
2015
Q3 		$35.6M Sell
630,789
-26,609
-4% -$1.73M 0.2% 126
2015
Q2 		$38.8M Buy
657,398
+11,834
+2% +$730K 0.2% 126
2015
Q1 		$40.2M Sell
645,564
-34,085
-5% -$1.98M 0.22% 119
2014
Q4 		$39.1M Buy
679,649
+56,964
+9% +$3.17M 0.22% 119
2014
Q3 		$33.5M Buy
622,685
+11,513
+2% +$610K 0.29% 69
2014
Q2 		$32M Sell
611,172
-125,459
-17% -$6.41M 0.29% 66
2014
Q1 		$38.9M Buy
+736,631
New +$34M 0.37% 42

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Stifel Financial's TEVA Position: Q2 2026 in Review

Stifel Financial reduced its Teva Pharmaceuticals (TEVA) stake by 4.4% in Q2 2026, selling an estimated $301K and leaving 198,546 shares worth $6.73M. The position accounts for 0.01% of the portfolio, ranked #1242.

Stifel Financial first reported a position in TEVA in Q1 2014 and has held it in 50 quarters since. The position peaked at $44.2M in Q4 2015. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Stifel Financial held 198,546 shares of Teva Pharmaceuticals worth $6.73M as of Q2 2026.
  • Stifel Financial sold 9,049 Teva Pharmaceuticals shares in Q2 2026, an estimated $301K.
  • Teva Pharmaceuticals made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #1242 holding.
  • Stifel Financial first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 50 quarters since.
  • Stifel Financial's Teva Pharmaceuticals position peaked at $44.2M in Q4 2015.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.